Fundz

Orna Fetches Seed Financing

RECENTLY ACQUIREDMay 25, 2022

Round Type

Seed

CambridgeBiotechnologyTherapeutics

Description

Toronto-based Orna, a security orchestration, automation and response platform for small and mid-size businesses, has raised more than C$1 million in seed financing.

Quick answer

Orna Therapeutics raised an undisclosed amount in a Seed round, dated May 25, 2022. Orna Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Orna Therapeutics raise?
Orna Therapeutics raised an undisclosed amount in a Seed round on May 25, 2022.
What does Orna Therapeutics do?
Orna Therapeutics was founded on groundbreaking research by Alex Wesselhoeft, Ph.D., and Daniel G. Anderson, Ph.D., from MIT and built by MPM Capital and BioImpact Capital, an affiliate of MPM.
Where is Orna Therapeutics based and how big is it?
Orna Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 180 employees.
Who are the decision-makers at Orna Therapeutics?
Fundz holds 1 contact at Orna Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Orna Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Faeth Therapeutics raised $47M (Funding Round) on June 30, 2022.
  • Centaurus Therapeutics raised $2M on June 28, 2022.
  • Aqualung Therapeutics Corp. raised $3.1M (Seed) on June 27, 2022.
  • Akero Therapeutics raised an undisclosed amount (Funding Round) on June 16, 2022.
  • RYNE Biotechnology raised $3M (Seed) on June 13, 2022.
  • ImmunOs Therapeutics AG raised an undisclosed amount (Series B) on June 7, 2022.

Who to call at Orna Therapeutics, and when

A new round usually means Orna Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Orna Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Orna Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Orna Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Orna Therapeutics

Location

Cambridge, Massachusetts, United States

About

Orna Therapeutics was founded on groundbreaking research by Alex Wesselhoeft, Ph.D., and Daniel G. Anderson, Ph.D., from MIT and built by MPM Capital and BioImpact Capital, an affiliate of MPM. Orna's proprietary circular RNA (oRNA) is engineered as linear RNA that self-circularizes. By taking a line and turning it into a circle, oRNA exhibits numerous advantages over traditional linear mRNA therapies such as simplified production, increased protein expression, and a superior immunogenicity profile. With proprietary lipid nanoparticles (LNPs), including those from Orna's joint venture with ReNAgade Therapeutics, an RNA delivery company, our technologies expand the possibilities of what RNA therapeutics can achieve. To learn more visit: www.ornatx.com and follow Orna Therapeutics on Twitter and LinkedIn. SOURCE Orna Therapeutics

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Orna Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTom B., Chief Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Orna Therapeutics's next move

See what Strategic adds

Orna Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.